Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Total Current Liabilities came in at $1.7 billion in Q1 2026, up 30.97% year-on-year from $1.3 billion in Q1 2025, and up 4.07% quarter-over-quarter from $1.6 billion in Q4 2025.
Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Total Current Liabilities across 10 years of filings, most recently posting $1.7 billion for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $1.7 billion, up 30.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 30.97% YoY), and the FY2025 annual result was $1.6 billion, up 21.44% from the prior year.
- Total Current Liabilities came in at $1.7 billion for Q1 2026 at Elanco Animal Health, up from $1.6 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.7 billion in Q4 2022 to a low of $1.2 billion in Q1 2024.
- The 5-year median for Total Current Liabilities is $1.3 billion (2022), against an average of $1.4 billion.
- Across the five-year window, Total Current Liabilities plunged 35.74% in 2022 and jumped 30.97% in 2026, its largest moves.
- Elanco Animal Health's Total Current Liabilities stood at $1.7 billion in 2022, then retreated by 27.09% to $1.2 billion in 2023, then gained by 5.96% to $1.3 billion in 2024, then grew by 21.44% to $1.6 billion in 2025, then gained by 4.07% to $1.7 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.7 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 149.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.60 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.36 Bn |
| Jun 30, 2021 | 1.99 Bn |